State Street Corp grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 0.7% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 45,633,267 shares of the healthcare conglomerate’s stock after buying an additional 301,081 shares during the quarter. State Street Corp owned 5.08% of UnitedHealth Group worth $18,966,555,000 at the end of the most recent quarter.
Other large investors have also added to or reduced their stakes in the company. BlackRock Inc. boosted its holdings in shares of UnitedHealth Group by 4.6% in the 2nd quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate’s stock worth $31,946,594,000 after purchasing an additional 3,395,530 shares in the last quarter. Capital World Investors boosted its stake in UnitedHealth Group by 3.8% in the fourth quarter. Capital World Investors now owns 22,591,042 shares of the healthcare conglomerate’s stock worth $7,457,723,000 after buying an additional 824,120 shares in the last quarter. Capital International Investors raised its stake in shares of UnitedHealth Group by 6.6% during the fourth quarter. Capital International Investors now owns 18,655,111 shares of the healthcare conglomerate’s stock worth $6,158,734,000 after acquiring an additional 1,155,162 shares in the last quarter. Norges Bank purchased a new stake in shares of UnitedHealth Group in the 4th quarter valued at $4,376,167,000. Finally, Bank of America Corp DE lifted its stake in UnitedHealth Group by 21.8% in the first quarter. Bank of America Corp DE now owns 11,713,684 shares of the healthcare conglomerate’s stock worth $3,169,606,000 after purchasing an additional 2,097,859 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.
UnitedHealth Group Trading Down 0.6%
Shares of UNH traded down $2.29 during mid-day trading on Tuesday, hitting $375.27. 1,589,809 shares of the company’s stock traded hands, compared to its average volume of 7,518,114. The business’s 50-day moving average price is $402.72 and its 200-day moving average price is $372.13. UnitedHealth Group Incorporated has a 1 year low of $255.96 and a 1 year high of $461.62. The firm has a market capitalization of $336.84 billion, a P/E ratio of 24.13, a PEG ratio of 1.42 and a beta of 0.61. The company has a quick ratio of 0.78, a current ratio of 0.78 and a debt-to-equity ratio of 0.66.
UnitedHealth Group Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 22nd. Investors of record on Monday, September 14th will be paid a $2.32 dividend. This represents a $9.28 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date of this dividend is Monday, September 14th. UnitedHealth Group’s dividend payout ratio is presently 59.72%.
Wall Street Analyst Weigh In
Several research firms have recently commented on UNH. Oppenheimer lifted their price objective on UnitedHealth Group from $420.00 to $500.00 and gave the stock an “outperform” rating in a report on Friday, July 17th. Truist Financial lifted their price target on UnitedHealth Group from $440.00 to $480.00 and gave the stock a “buy” rating in a research note on Tuesday, July 14th. Royal Bank Of Canada increased their price objective on UnitedHealth Group from $463.00 to $478.00 and gave the company an “outperform” rating in a research note on Friday, July 17th. Sanford C. Bernstein reiterated an “outperform” rating on shares of UnitedHealth Group in a report on Wednesday, September 2nd. Finally, Bank of America reissued a “buy” rating on shares of UnitedHealth Group in a report on Monday, July 20th. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and seven have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $456.56.
Check Out Our Latest Stock Analysis on UNH
Insiders Place Their Bets
In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of the company’s stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the transaction, the chief executive officer owned 15,328 shares in the company, valued at approximately $5,977,920. This represents a 7.09% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.19% of the company’s stock.
UnitedHealth Group Profile
UnitedHealth Group Incorporated is a diversified health care and well-being company headquartered in Minnetonka, Minnesota. Its operations are organized primarily through two businesses: UnitedHealthcare, which provides health benefit plans and services, and Optum, which delivers health care services, technology, pharmacy care and data-driven solutions.
UnitedHealthcare serves individuals, employers, government programs and other organizations through products that include employer-sponsored health plans, individual and family coverage, Medicare and Medicaid plans, dental and vision benefits, and related administrative services.
See Also
- Five stocks we like better than UnitedHealth Group
- IonQ’s AI Breakthrough Looks Big—But Can It Drive Revenue?
- Broadcom CEO Holds $350B Outlook Strong Amid Calls to Slow Froniter AI Development
- Microsoft’s 8% Dividend Hike: Confidence Signal or Distraction From Capex Math?
- Paramount Skydance Clears a Major Warner Bros. Discovery Hurdle—Here’s What Comes Next
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
